GeneMatrix Inc (109820) — Financial Flexibility Index
GeneMatrix Inc (109820) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of ₩523.83 Million (operating CF ₩500.19 Million minus capex ₩23.65 Million) represents 0% of total liabilities (₩9.72 Billion). Check GeneMatrix Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GeneMatrix Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for GeneMatrix Inc across 11 annual periods. For the full cash flow conversion analysis, see how efficiently does GeneMatrix Inc generate cash.
Annual Financial Flexibility Index for GeneMatrix Inc (2014–2024)
Year-by-year free cash flow to debt coverage for GeneMatrix Inc. Explore 109820 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.02x | ₩-166.46 Million | ₩-200.12 Million | ₩9.23 Billion | ▲ +93.2% |
| 2023 | -0.27x | ₩-2.18 Billion | ₩-2.35 Billion | ₩8.21 Billion | ▼ -141.6% |
| 2022 | -0.11x | ₩-850.50 Million | ₩-1.02 Billion | ₩7.72 Billion | ▼ -121.9% |
| 2021 | 0.50x | ₩3.63 Billion | ₩3.37 Billion | ₩7.21 Billion | ▼ -50.7% |
| 2020 | 1.02x | ₩4.87 Billion | ₩4.51 Billion | ₩4.78 Billion | ▲ +745.8% |
| 2019 | -0.16x | ₩-2.09 Billion | ₩-2.28 Billion | ₩13.21 Billion | ▼ -36.5% |
| 2018 | -0.12x | ₩-2.39 Billion | ₩-2.74 Billion | ₩20.68 Billion | ▲ +51.4% |
| 2017 | -0.24x | ₩-1.59 Billion | ₩-1.77 Billion | ₩6.68 Billion | ▼ -1494.9% |
| 2016 | -0.01x | ₩-102.30 Million | ₩-373.25 Million | ₩6.85 Billion | ▲ +68.7% |
| 2015 | -0.05x | ₩-513.06 Million | ₩-591.96 Million | ₩10.74 Billion | ▲ +77.8% |
| 2014 | -0.22x | ₩-1.11 Billion | ₩-1.38 Billion | ₩5.16 Billion | — |